JPWO2023214509A5 - - Google Patents

Info

Publication number
JPWO2023214509A5
JPWO2023214509A5 JP2024519189A JP2024519189A JPWO2023214509A5 JP WO2023214509 A5 JPWO2023214509 A5 JP WO2023214509A5 JP 2024519189 A JP2024519189 A JP 2024519189A JP 2024519189 A JP2024519189 A JP 2024519189A JP WO2023214509 A5 JPWO2023214509 A5 JP WO2023214509A5
Authority
JP
Japan
Prior art keywords
peptide compound
surfactant
following
composition
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519189A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023214509A1 (https=
Filing date
Publication date
Priority claimed from TW111138589A external-priority patent/TW202330014A/zh
Application filed filed Critical
Priority claimed from PCT/JP2023/015658 external-priority patent/WO2023214509A1/ja
Publication of JPWO2023214509A1 publication Critical patent/JPWO2023214509A1/ja
Publication of JPWO2023214509A5 publication Critical patent/JPWO2023214509A5/ja
Pending legal-status Critical Current

Links

JP2024519189A 2022-05-02 2023-04-19 Pending JPWO2023214509A1 (https=)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2022075833 2022-05-02
EP22192611 2022-08-29
TW111138589A TW202330014A (zh) 2021-10-13 2022-10-12 含有胜肽化合物及界面活性劑之組成物
EP22200995.3A EP4166133B1 (en) 2021-10-13 2022-10-12 Composition containing peptide compound and surfactant
PCT/JP2022/038128 WO2023063376A1 (ja) 2021-10-13 2022-10-12 ペプチド化合物及び界面活性剤を含む組成物
PCT/JP2023/015658 WO2023214509A1 (ja) 2022-05-02 2023-04-19 界面活性剤と併用するためのペプチド化合物を含む組成物

Publications (2)

Publication Number Publication Date
JPWO2023214509A1 JPWO2023214509A1 (https=) 2023-11-09
JPWO2023214509A5 true JPWO2023214509A5 (https=) 2026-01-07

Family

ID=88646467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519189A Pending JPWO2023214509A1 (https=) 2022-05-02 2023-04-19

Country Status (7)

Country Link
US (1) US20250186542A1 (https=)
EP (1) EP4406546A4 (https=)
JP (1) JPWO2023214509A1 (https=)
KR (1) KR20250002095A (https=)
CN (1) CN118354782A (https=)
TW (1) TW202406566A (https=)
WO (1) WO2023214509A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202446781A (zh) 2011-12-28 2024-12-01 日商中外製藥股份有限公司 胜肽化合物之製造方法
TW202506168A (zh) * 2023-04-19 2025-02-16 日商中外製藥股份有限公司 包含環狀胜肽化合物及界面活性劑之組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679277A5 (https=) * 1989-02-09 1992-01-31 Sandoz Ag
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
TW200409644A (en) * 2002-12-04 2004-06-16 Bio Max Inc Improved carrier system for cyclosporin pharmaceutical compositions
US8093207B2 (en) 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
WO2011162830A2 (en) * 2010-06-24 2011-12-29 Biousian Biosystems, Inc. Glucagon-like peptide-1 glycopeptides
CA2839408A1 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
TW202446781A (zh) 2011-12-28 2024-12-01 日商中外製藥股份有限公司 胜肽化合物之製造方法
IN2015DN03132A (https=) * 2012-09-17 2015-10-02 Tarix Pharmaceuticals Ltd
WO2016004067A1 (en) * 2014-06-30 2016-01-07 Stealth Biotherapeutics Corp Aromatic-cationic peptide formulations, compositions and methods of use
CN110869544B (zh) 2017-06-09 2024-03-08 中外制药株式会社 膜透过性高的环状肽化合物及包含其的文库
KR20250007021A (ko) * 2017-06-09 2025-01-13 추가이 세이야쿠 가부시키가이샤 N-치환 아미노산을 포함하는 펩타이드의 합성 방법
BR112022007535A2 (pt) 2019-11-07 2022-07-12 Chugai Pharmaceutical Co Ltd Composto peptídico cíclico tendo ação inibitória de kras

Similar Documents

Publication Publication Date Title
JPWO2023214509A5 (https=)
JP2022530043A5 (https=)
JP2024542188A5 (https=)
EP0572014B1 (en) Hair-growing composition containing prostaglandin I 2 derivatives
JP7130818B2 (ja) 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
CA1132901A (en) Aniline x-ray agent and buffer whose ph decreases with temperature
BR0017437A (pt) Composições farmacêuticas contendo polipéptido líquidas estabilizadas
KR890000091A (ko) 특정 1,4-디히드로피리딘 유도체의 피부전달을 위한 향상제
CA2485850A1 (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure
RU2015104031A (ru) Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
JPWO2023063376A5 (https=)
KR870700067A (ko) 피리도(2,3-d)-피리미딘 유도체
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
RU2004119056A (ru) Составленные на основе воды фармацевтические композиции водорастворимых пролекарств пропофола
CA2375727A1 (en) Cytofectin dimers and methods of use thereof
JP7466609B2 (ja) 析出抑制剤
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR880006205A (ko) 치환된 1h-이미다졸
RU2006101676A (ru) Композиции для полоскания полости рта, содержащие соли алкиловых эфиров n-ациларгинина
WO2020025825A1 (fr) Solution injectable a ph 7 comprenant du glucagon humain, au moins une espece ionique et un compose amphiphile porteur de radicaux hydrophobes
JP4820648B2 (ja) ロテプレドノールエタボネート水性懸濁液剤
JP4092507B2 (ja) プロスタグランジン含有製品
JP2007537282A5 (https=)
CN1227489A (zh) 腺嘌呤核苷脱氨酶抑制剂